Virtual Congress – 8th World Congress on ADHD 2021
mei 6 - mei 9
Due to COVID-19 and the lasting high infection rates in the Czech Republic the organizers of the 8th World Congress on ADHD scheduled for 6 – 9 May 2021 have decided to present the congress as a virtual event only. This is an exciting opportunity for the global ADHD community to experience this innovative methodology in such a wide-ranging way for the first time. The Preliminary Programme is now available here and there will be a reduction in registration fees.
What else has the virtual ADHD Congress to offer?
- Educational Seminars (ES) and Meet the Expert Sessions (ME) will take place parallel to the scientific programme.
- A virtual poster exhibition – sorted by topics – is open to all participants during and after the ADHD Congress.
- A virtual exhibition and satellite symposia presented by the industry.
- CME points are applied at the UEMS-EACCME® (The European Accreditation Council for CME).
- All sessions will also be available on demand after the ADHD congress.
Come and visit www.adhd-congress.org.
From Child to Adult Disorder
The WFADHD educates the world about ADHD and advocates for patients and their families at a biennial meeting where world experts teach clinicians, researchers and other ADHD stakeholders how to use scientific facts and clinical wisdom to create better outcomes for people with ADHD. WFADHD has had a dramatic impact on the field. We have seen in our meeting participation, which has averaged 1,450 delegates per meeting for the last four meetings. Delegates are attracted by our wide range of offerings, from basic science breakthroughs to clinical workshops by master clinicians. The high quality of our meetings derives from the many thought leaders who participate as speakers or attendees.
We are confident that our 8th World Congress on ADHD will continue to impact our field. The World Congress has been a key meeting for acquiring the most recent and authoritative information on the aetiology, pathophysiology, clinical management and treatment of ADHD and comorbid disorders in both children and adults. By bringing together clinical psychiatrists, psychologists, psychotherapists, neuroscientists, primary care practitioners and allied health care professionals, the World Congress promotes exchange of basic and clinical science ideas to improve outcomes for patients.
We will create an outstanding program of scientific sessions and clinical workshops by soliciting input from the many members of our International Scientific Programme Committee. We will have plenary sessions, hot topic symposia, one or more pro-con debates, video sessions, educational seminars, meet-the-expert-sessions, as well as guided poster tours. This year, Eunethydis will create a special program for junior members which will help us our youngest scientists and clinicians devoted to the field of ADHD.